CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Ankur Drugs and Pharma Limited is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Ankur Drugs and Pharma Limited
20Th Floor, Lotus Business Park
Andheri Link Road
Phone: +91 2240682300p:+91 2240682300 Mumbai, 400053  India Ticker: ANKURDRUGSANKURDRUGS
This company is no longer actively traded on any major stock exchange.
Business Summary
Ankur Drugs and Pharma Limited is an India-based company, which is engaged in manufacturing pharmaceutical formulations. The Company has various dosage forms, which includes tablets, capsules, dry syrups, liquid orals, injectables and ointments. The Company's products are categorized as general products, cephalosporin products and betalactum products. Its general products include antidiarrhoels, antiallergics, antipyretics and antidepressant. Its cephalosporin products include cefixime tablets, cefpodoxime proxetil for oral suspension, alpha-beta arteether injection, cefuroxime sodium injection IP and cefepime injection USP. Its betalactum products include amoxycillin oral suspension, amoxycillin and potassium clavulanate tablets, amoxycillin redimix, amoxycillin and dicloxacillin capsules, and ampicillin capsule. The Company also offers contract manufacturing services.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/20123/31/2012Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Managing Director PurnanduJain 48 8/23/2003 8/23/2003
Compliance Officer, Company Secretary S. C.Rane
Wholetime Executive Director GirrajVijayvargiya 44 4/2/2006 4/2/2006
Non-Executive Independent Director RameshBatham 46 10/14/2010 10/14/2010
Non-Executive Independent Director Dileep H.Shinde 64 8/31/2004 8/31/2004

General Information
Number of Employees: 1,245 (As of 3/31/2012)
Outstanding Shares: 19,341,590 (As of 9/30/2012)
Shareholders: 22,980
Stock Exchange: NSE
Fax Number: +91 2240682323


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023